GB9113011D0 - Novel treatment and compositions - Google Patents

Novel treatment and compositions

Info

Publication number: GB9113011D0
Authority: GB; United Kingdom
Prior art keywords: compositions; novel treatment; novel; treatment
Prior art date: 1991-06-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB919113011A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Original Assignee

SmithKline Beecham Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-17

Filing date

1991-06-17

Publication date

1991-08-07

1991-06-17 Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd

1991-06-17 Priority to GB919113011A priority Critical patent/GB9113011D0/en

1991-08-07 Publication of GB9113011D0 publication Critical patent/GB9113011D0/en

1992-06-16 Priority to EP92912481A priority patent/EP0589989A1/en

1992-06-16 Priority to PCT/GB1992/001079 priority patent/WO1992022329A1/en

1992-06-16 Priority to AU20203/92A priority patent/AU662911B2/en

1992-06-16 Priority to JP5500791A priority patent/JPH06508615A/en

1992-06-16 Priority to CA002111584A priority patent/CA2111584A1/en

1992-06-17 Priority to NZ243176A priority patent/NZ243176A/en

1992-06-17 Priority to MX9202932A priority patent/MX9202932A/en

1992-06-17 Priority to PT100595A priority patent/PT100595A/en

1992-06-17 Priority to ZA924428A priority patent/ZA924428B/en

1992-07-01 Priority to IE196592A priority patent/IE921965A1/en

Status Pending legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Obesity (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

GB919113011A 1991-06-17 1991-06-17 Novel treatment and compositions Pending GB9113011D0 (en)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
GB919113011A GB9113011D0 (en)	1991-06-17	1991-06-17	Novel treatment and compositions
CA002111584A CA2111584A1 (en)	1991-06-17	1992-06-16	Use of b-cell tropin (acth 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases
JP5500791A JPH06508615A (en)	1991-06-17	1992-06-16	Use of β-cell tropin (ACTH22-39) antagonists in the treatment of hyperinsulinemia and related diseases
PCT/GB1992/001079 WO1992022329A1 (en)	1991-06-17	1992-06-16	USE OF β-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES
AU20203/92A AU662911B2 (en)	1991-06-17	1992-06-16	Use of beta-cell tropin (ACTH 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases
EP92912481A EP0589989A1 (en)	1991-06-17	1992-06-16	USE OF $g(b)-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES
NZ243176A NZ243176A (en)	1991-06-17	1992-06-17	Compounds and compositions thereof that regulate the formation release or biological activity of beta-cell tropin
MX9202932A MX9202932A (en)	1991-06-17	1992-06-17	COMPOUND TO REGULATE THE FORMATION OF THE CELL BETA-TROPIN.
PT100595A PT100595A (en)	1991-06-17	1992-06-17	Process for the preparation of a pharmaceutical composition comprising a compound that regulates the formation, release or biological activity of the cells of the cellobetas (BETA-CT), for example a specific antibody to BETA-CT, and use of the compound compound for the production of medicaments
ZA924428A ZA924428B (en)	1991-06-17	1992-06-17	Pharmaceuticals and use.
IE196592A IE921965A1 (en)	1991-06-17	1992-07-01	Pharmaceuticals and use

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919113011A GB9113011D0 (en)	1991-06-17	1991-06-17	Novel treatment and compositions

Publications (1)

Publication Number	Publication Date
GB9113011D0 true GB9113011D0 (en)	1991-08-07

Family

ID=10696802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB919113011A Pending GB9113011D0 (en)	1991-06-17	1991-06-17	Novel treatment and compositions

Country Status (11)

Country	Link
EP (1)	EP0589989A1 (en)
JP (1)	JPH06508615A (en)
AU (1)	AU662911B2 (en)
CA (1)	CA2111584A1 (en)
GB (1)	GB9113011D0 (en)
IE (1)	IE921965A1 (en)
MX (1)	MX9202932A (en)
NZ (1)	NZ243176A (en)
PT (1)	PT100595A (en)
WO (1)	WO1992022329A1 (en)
ZA (1)	ZA924428B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989006135A1 (en) *	1988-01-11	1989-07-13	Amylin Corporation	Treatment of type 2 diabetes mellitus

1991
- 1991-06-17 GB GB919113011A patent/GB9113011D0/en active Pending
1992
- 1992-06-16 EP EP92912481A patent/EP0589989A1/en not_active Withdrawn
- 1992-06-16 CA CA002111584A patent/CA2111584A1/en not_active Abandoned
- 1992-06-16 WO PCT/GB1992/001079 patent/WO1992022329A1/en not_active Application Discontinuation
- 1992-06-16 JP JP5500791A patent/JPH06508615A/en active Pending
- 1992-06-16 AU AU20203/92A patent/AU662911B2/en not_active Ceased
- 1992-06-17 PT PT100595A patent/PT100595A/en not_active Application Discontinuation
- 1992-06-17 ZA ZA924428A patent/ZA924428B/en unknown
- 1992-06-17 NZ NZ243176A patent/NZ243176A/en unknown
- 1992-06-17 MX MX9202932A patent/MX9202932A/en unknown
- 1992-07-01 IE IE196592A patent/IE921965A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
PT100595A (en)	1993-08-31
AU662911B2 (en)	1995-09-21
MX9202932A (en)	1993-06-01
CA2111584A1 (en)	1992-12-23
IE921965A1 (en)	1992-12-30
JPH06508615A (en)	1994-09-29
WO1992022329A1 (en)	1992-12-23
EP0589989A1 (en)	1994-04-06
NZ243176A (en)	1995-04-27
ZA924428B (en)	1993-06-23
AU2020392A (en)	1993-01-12

Publication	Publication Date	Title
GB9208339D0 (en)	1992-06-03	Treatment composition
IL104107A0 (en)	1993-05-13	New compounds and compositions
GB9121289D0 (en)	1991-11-20	Composition and use
HK1094148A1 (en)	2007-03-23	Synergistic therapeutic compositions and methods
GB9127150D0 (en)	1992-02-19	Novel treatment
HU9400190D0 (en)	1994-05-30	Therapeutic compositions and methods
GB9114526D0 (en)	1991-08-21	Compositions and use thereof
ZA919024B (en)	1992-09-30	Anthelmintic treatment and compositions
GB9007730D0 (en)	1990-06-06	Therapeutic compound and composition
GB9103631D0 (en)	1991-04-10	Composition and use
ZA916967B (en)	1992-08-26	Topical treatment and composition
GB9016027D0 (en)	1990-09-05	Composition and use
GB9113042D0 (en)	1991-08-07	Novel treatment and compositions
GB9113039D0 (en)	1991-08-07	Novel treatment and compositions
GB9113011D0 (en)	1991-08-07	Novel treatment and compositions
GB9113038D0 (en)	1991-08-07	Novel treatment and compositions
GB9120646D0 (en)	1991-11-06	Hair treatment composition
GB9113040D0 (en)	1991-08-07	Novel treatments and compositions
GB9113041D0 (en)	1991-08-07	Novel treatments and compositions
GB9022298D0 (en)	1990-11-28	Treatment composition
ZA919022B (en)	1992-09-30	Anthelmintic treatment and compositions
ZA923194B (en)	1993-01-27	Dental treatment compositions
ZA909765B (en)	1991-09-25	Vitamin-mineral treatment methods and compositions
GB9116906D0 (en)	1991-09-18	Composition and use
GB9105560D0 (en)	1991-05-01	Novel treatment i